BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9089801)

  • 1. Plasma levels of leukotriene E4 during clinical course of chronic obstructive pulmonary disease.
    Shindo K; Hirai Y; Fukumura M; Koide K
    Prostaglandins Leukot Essent Fatty Acids; 1997 Mar; 56(3):213-7. PubMed ID: 9089801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of leukotriene E4 during clinical course of bronchial asthma and the effect of oral prednisolone.
    Shindo K; Fukumura M; Miyakawa K
    Chest; 1994 Apr; 105(4):1038-41. PubMed ID: 8162721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary excretion of leukotriene E4 and eosinophil protein X in children with atopic asthma.
    Severien C; Artlich A; Jonas S; Becher G
    Eur Respir J; 2000 Oct; 16(4):588-92. PubMed ID: 11106196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukotriene B4 levels in the arterial blood of asthmatic patients and the effects of prednisolone.
    Shindo K; Fukumura M; Miyakawa K
    Eur Respir J; 1995 Apr; 8(4):605-10. PubMed ID: 7664862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in urinary leukotriene LTE4 levels in acute asthma: correlation with airflow limitation.
    Green SA; Malice MP; Tanaka W; Tozzi CA; Reiss TF
    Thorax; 2004 Feb; 59(2):100-4. PubMed ID: 14760145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Measurement of bronchoconstrictive eicosanoids in chronic obstructive pulmonary disease].
    Gross-Sondej I; Soja J; Sładek K; Pulka G; Skucha W; Niżankowska-Mogilnicka E
    Pneumonol Alergol Pol; 2012; 80(2):120-6. PubMed ID: 22370980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strenuous exercise increases plasmatic and urinary leukotriene E4 in cyclists.
    Caillaud C; Le Creff C; Legros P; Denjean A
    Can J Appl Physiol; 2003 Dec; 28(6):793-806. PubMed ID: 14992122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent increase in plasma and urinary leukotrienes after acute asthma.
    Sampson AP; Castling DP; Green CP; Price JF
    Arch Dis Child; 1995 Sep; 73(3):221-5. PubMed ID: 7492159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of aspirin desensitization on urinary leukotriene E4 concentrations in aspirin-sensitive asthma.
    Nasser SM; Patel M; Bell GS; Lee TH
    Am J Respir Crit Care Med; 1995 May; 151(5):1326-30. PubMed ID: 7735581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukotriene E4 plasma levels in adult asthmatic patients with variable disease severity.
    Chavis C; van Vyve T; Chanez P; Farce M; Bousquet J; Michel FB; Godard P
    Allergy; 1997 May; 52(5):589-92. PubMed ID: 9201374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a highly sensitive liquid chromatography-mass spectrometry method to quantify plasma leukotriene E
    Löfgren L; Forsberg GB; Davidsson P; Eketjäll S; Whatling C
    Prostaglandins Other Lipid Mediat; 2020 Oct; 150():106463. PubMed ID: 32450304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary leukotriene E4 levels in patients with atopic dermatitis.
    Sansom JE; Taylor GW; Dollery CT; Archer CB
    Br J Dermatol; 1997 May; 136(5):790-1. PubMed ID: 9205521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid reversibility test followed by inhaled budesonide or placebo in outpatients with stable chronic obstructive pulmonary disease. The Danish Society of Respiratory Medicine.
    Senderovitz T; Vestbo J; Frandsen J; Maltbaek N; Nørgaard M; Nielsen C; Kampmann JP
    Respir Med; 1999 Oct; 93(10):715-8. PubMed ID: 10581660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary leukotriene E4 in bronchial asthma.
    Smith CM; Hawksworth RJ; Thien FC; Christie PE; Lee TH
    Eur Respir J; 1992 Jun; 5(6):693-9. PubMed ID: 1321055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin induced asthma (AIA) with nasal polyps has the highest basal LTE4 excretion: a study vs AIA without polyps, mild topic asthma, and normal controls.
    Micheletto C; Visconti M; Tognella S; Facchini FM; Dal Negro RW
    Eur Ann Allergy Clin Immunol; 2006 Jan; 38(1):20-3. PubMed ID: 16544584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy.
    Kamischke A; Kemper DE; Castel MA; Lüthke M; Rolf C; Behre HM; Magnussen H; Nieschlag E
    Eur Respir J; 1998 Jan; 11(1):41-5. PubMed ID: 9543268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High levels of urinary leukotriene E4 excretion in steroid treated patients with severe asthma.
    Vachier I; Kumlin M; Dahlén SE; Bousquet J; Godard P; Chanez P
    Respir Med; 2003 Nov; 97(11):1225-9. PubMed ID: 14635978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral corticosteroid trials in the management of stable chronic obstructive pulmonary disease.
    Davies L; Nisar M; Pearson MG; Costello RW; Earis JE; Calverley PM
    QJM; 1999 Jul; 92(7):395-400. PubMed ID: 10627889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle metabolic status in patients with severe COPD with and without long-term prednisolone.
    Pouw EM; Koerts-de Lang E; Gosker HR; Freling G; van der Vusse GJ; Wouters EF; Schols AM
    Eur Respir J; 2000 Aug; 16(2):247-52. PubMed ID: 10968499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of forced expiratory volume in 1 s in screening subjects with stable COPD for PaO2 < 7.3 kPa qualifying for long-term oxygen therapy.
    Lim S; MacRae KD; Seed WA; Roberts CM
    Respir Med; 1998 Sep; 92(9):1122-6. PubMed ID: 9926166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.